|
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
| Capitalization1 |
31 100 | 42 831 | 50 134 | 44 134 | - | - |
| Entreprise Value (EV)1 |
63 426 | 75 150 | 83 235 | 74 141 | 74 233 | 73 313 |
| P/E ratio |
14,8x | 11,7x | 14,7x | 12,2x | 10,9x | 9,81x |
| Yield |
- | 1,12% | 1,10% | 0,33% | 1,30% | 1,52% |
| Capitalization / Revenue |
0,71x | 0,92x | 0,98x | 0,86x | 0,81x | 0,78x |
| EV / Revenue |
1,45x | 1,61x | 1,62x | 1,45x | 1,37x | 1,29x |
| EV / EBITDA |
7,70x | 8,40x | 8,44x | 7,55x | 7,10x | 6,63x |
| Price to Book |
-4,70x | -8,62x | -18,3x | 747x | 16,7x | 10,4x |
| Nbr of stocks (in thousands) |
354 053 | 344 161 | 339 178 | 338 033 | - | - |
| Reference price (USD) |
87,8 | 124 | 148 | 131 | 131 | 131 |
| Last update |
01/30/2018 | 01/29/2019 | 01/28/2020 | 10/28/2020 | 10/28/2020 | 10/28/2020 |
|
1 USD in Million Estimates
|
|
| Income Statement Evolution | |
|
|
|
| Annual Income Statement Data |
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
| Net sales1 |
43 614 | 46 677 | 51 336 | 51 163 | 54 217 | 56 875 |
| EBITDA1 |
8 233 | 8 949 | 9 857 | 9 825 | 10 456 | 11 065 |
| Operating profit (EBIT)1 |
6 102 | 6 671 | 7 261 | 7 077 | 7 634 | 8 114 |
| Operating Margin |
14,0% | 14,3% | 14,1% | 13,8% | 14,1% | 14,3% |
| Pre-Tax Profit (EBT)1 |
4 381 | 5 335 | 5 244 | 5 096 | 6 003 | 6 559 |
| Net income1 |
2 216 | 3 787 | 3 505 | 3 733 | 4 151 | 4 480 |
| Net margin |
5,08% | 8,11% | 6,83% | 7,30% | 7,66% | 7,88% |
| EPS2 |
5,95 | 10,7 | 10,1 | 10,7 | 12,0 | 13,3 |
| Dividend per Share2 |
- | 1,40 | 1,63 | 0,43 | 1,70 | 1,98 |
| Last update |
01/30/2018 | 01/29/2019 | 01/28/2020 | 10/28/2020 | 10/28/2020 | 10/28/2020 |
|
1 USD in Million 2 USD Estimates
|
|
|
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
| Net Debt1 |
32 326 | 32 319 | 33 101 | 30 007 | 30 099 | 29 179 |
| Net Cash position1 |
- | - | - | - | - | - |
| Leverage (Debt / EBITDA) |
3,93x | 3,61x | 3,36x | 3,05x | 2,88x | 2,64x |
| Free Cash Flow1 |
2 411 | 3 188 | 3 444 | 5 540 | 2 973 | 4 338 |
| ROE (Net Profit / Equities) |
- | - | - | - | 167% | 96,6% |
| Shareholders' equity1 |
- | - | - | - | 2 486 | 4 640 |
| ROA (Net Profit / Asset) |
6,30% | 9,99% | 8,32% | 7,62% | 8,06% | 9,22% |
| Assets1 |
35 176 | 37 900 | 42 127 | 49 017 | 51 529 | 48 568 |
| Book Value Per Share2 |
-18,7 | -14,4 | -8,06 | 0,17 | 7,81 | 12,6 |
| Cash Flow per Share2 |
14,6 | 19,0 | 21,8 | 27,1 | 15,5 | 23,3 |
| Capex1 |
3 015 | 3 573 | 4 158 | 3 076 | 3 852 | 4 128 |
| Capex / Sales |
6,91% | 7,65% | 8,10% | 6,01% | 7,10% | 7,26% |
| Last update |
01/30/2018 | 01/29/2019 | 01/28/2020 | 10/28/2020 | 10/28/2020 | 10/28/2020 |
|
1 USD in Million 2 USD Estimates
|
|
|
|
|
|
Financial data source
© 2020 S&P Global Market Intelligence
|
|
|
Former KKR dealmaker launches healthcare-focused buyout firm |
Capitalization (USD) 44 133 627 648 Net sales (USD) 51 336 000 000 Number of employees 245 000 Sales / Employee (USD) 209 535 Free-Float capitalization (USD) 34 561 228 001 Avg. Exchange 20 sessions (USD) 193 271 115 Average Daily Capital Traded 0,44%
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Evolution Valeur d'Entreprise / EBITDA
|
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
